Form D · Other Technology
Salus Labs, Inc.
San Francisco, CA · CIK 0001776609
Offering snapshot reported May 13, 2019 · SEC filing
- Reported sold
- $35M Offering amount: $35M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 8, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2019 | Initial | $34,999,994 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-339440
Source: Form D, filed May 13, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ammon Bartram | Director |
| Guillaume Luccisano | Director |
| Ali Rowghani | Director |
| Harjeet Taggar | Director, Executive |
| Garry Tan | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
301 Howard Street, Suite 550
San Francisco, CA, 94105
San Francisco, CA, 94105